NRG
LLY icon

Nemes Rush Group’s Eli Lilly LLY Stock Holding History

Nemes Rush Group’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$18.7M Buy
15,575
+378
+2% +$386K 1.54% 22
2026
Q1 		$14M Sell
15,197
-164
-1% -$166K 1.33% 27
2025
Q4 		$16.5M Buy
15,361
+94
+0.6% +$89.9K 1.55% 20
2025
Q3 		$11.6M Buy
15,267
+369
+2% +$275K 1.15% 27
2025
Q2 		$11.6M Buy
14,898
+553
+4% +$430K 1.26% 26
2025
Q1 		$11.8M Buy
14,345
+204
+1% +$170K 1.5% 22
2024
Q4 		$10.9M Buy
14,141
+835
+6% +$691K 1.35% 26
2024
Q3 		$10.4M Sell
13,306
-392
-3% -$352K 1.5% 23
2024
Q2 		$12.4M Buy
13,698
+326
+2% +$261K 1.7% 18
2024
Q1 		$10.4M Buy
13,372
+10,433
+355% +$7.42M 1.49% 23
2023
Q4 		$1.71M Sell
2,939
-132
-4% -$77K 0.28% 67
2023
Q3 		$1.65M Sell
3,071
-36
-1% -$18.6K 0.3% 68
2023
Q2 		$1.46M Buy
+3,107
New +$1.3M 0.26% 74

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Nemes Rush Group's LLY Position: Q2 2026 in Review

Nemes Rush Group increased its Eli Lilly (LLY) stake by 2.5% in Q2 2026, buying an estimated $386K and bringing the position to 15,575 shares worth $18.7M. The position accounts for 1.54% of the portfolio, ranked #22.

Nemes Rush Group first reported a position in LLY in Q2 2023 and has held it in 13 quarters since. 4,630 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Nemes Rush Group held 15,575 shares of Eli Lilly worth $18.7M as of Q2 2026.
  • Nemes Rush Group bought 378 Eli Lilly shares in Q2 2026, an estimated $386K.
  • Eli Lilly made up 1.54% of Nemes Rush Group's portfolio in Q2 2026, its #22 holding.
  • Nemes Rush Group first reported a position in Eli Lilly in Q2 2023 and has held it in 13 quarters since.
  • 4,630 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Nemes Rush Group's 13F filing for Q2 2026, filed 14 Aug 2026.